Children and the global tuberculosis situation

Donald A Enarson1

  • 1International Union Against Tuberculosis and Lung Disease, Paris, France. union@iuatld.org

Insights

Directly Observed Treatment, Short-course (DOTS) effectively reduces tuberculosis in communities, protecting children. However, a vaccine is still needed for complete eradication of Mycobacterium tuberculosis.

Area of Science:

  • Public Health
  • Infectious Disease Control
  • Pediatric Health

Background:

  • The global strategy for tuberculosis control, Directly Observed Treatment, Short-course (DOTS), prioritizes sputum smear-positive cases.
  • Children with tuberculosis are rarely sputum smear-positive, leading to a misconception that they are unimportant in control efforts.
  • Eradication of Mycobacterium tuberculosis requires strategies beyond current treatment protocols, as no vaccine currently exists.

Purpose of the Study:

  • To evaluate the effectiveness of managing infectious tuberculosis cases in adults as a means to protect children from infection.
  • To assess the impact of tuberculosis control strategies on pediatric tuberculosis incidence and prevalence in low-income settings.
  • To highlight the urgent need for a vaccine to prevent Mycobacterium tuberculosis infection in children for disease eradication.

Main Methods:

  • Analysis of tuberculosis control data from Beijing Municipality, China, following the implementation of the DOTS strategy since 1978.
  • Comparison of tuberculosis prevalence and incidence trends before and after the expansion of DOTS.
  • Monitoring of pediatric tuberculosis, specifically tuberculous meningitis, in relation to adult case management and community infection levels.

Main Results:

  • Implementation of DOTS led to a rapid reduction in tuberculosis prevalence in the Beijing community.
  • Tuberculous meningitis virtually disappeared, and the prevalence of tuberculous infection declined significantly.
  • While adult case management reduced childhood exposure, it was insufficient for complete protection, indicating a need for additional interventions.

Conclusions:

  • Efficient management of adult tuberculosis patients significantly reduces infection risk for children.
  • Current strategies, while impactful, are insufficient for the complete eradication of Mycobacterium tuberculosis.
  • Development of an effective vaccine to prevent Mycobacterium tuberculosis infection in children is crucial for ultimate disease eradication.

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...